$ALKS..$57.53..FDA says it needs more time to review Alkermes' aripiprazole lauroxil NDA http://seekingalpha.com/news/2741816-fda-says-it-needs-more-time-to-review-alkermes-aripiprazole-lauroxil-nda?source=twitter_sa_healthinvest …